Primary non-secretory plasma cell leukemia with atypical morphology — a case report
نویسندگان
چکیده
منابع مشابه
Hodgkin’s Lymphoma Occurring Secondary to Autologous Stem Cell Transplantation in Plasma Cell Leukemia; A Case Report
Survival of patients with multiple myeloma has improved substantially because of availability of new therapies including autotransplants, immunomodulating drugs and proteasome-inhibitors. Second primary cancers have emerged as an important determinant of morbidity and mortality among cancer survivors. Even though there is an increased risk of new cancers of the lymphoreticular and haematopoetic...
متن کاملA Rare Case of Non Secretory Plasma Cell Leukemia with Unusual Morphology and Aberrant Expression of CD23 and CD56
Primary non-secretory Plasma cell leukemiaisa rare diagnosis with only few cases reported so far. Here we report a case of a non secretory Plasma cell leukemia diagnosed on flow cytometry, as atypical morphology and negative serum and urine protein electrophoresis made it difficult to come to a conclusive diagnosis based on morphology.
متن کاملPrimary plasma cell leukemia with unusual morphology and complex karyotype.
Correspondence: Eduardo Rocha, M.D., Department of Hematology, University Clinic, Avda. Pío XII s/n, Pamplona 31008, Spain. Phone: international +34-948-296397 • Fax: international +34-948296500 • E-mail: [email protected] istics seem to be related to a worse prognosis than the usual well-differentiated myeloma and give rise to a differential diagnosis of myeloid or monocytic leukemia, lymphoma or ...
متن کاملPrimary plasma cell leukaemia--a case report.
Plasma cell leukemia is a rare disease entity where the number of clonal plasma cells in the peripheral blood exceeds 2X10 9 /l or 20% of the total leukocyte count. This plasma cell leukemia can be primary which is arising denovo or secondary as in the course of plasma cell myeloma. A 40 year old female who came to the outpatient department with complaints of low back pain for 3 months and had ...
متن کاملEffective treatment of primary plasma cell leukemia with thalidomide and dexamethasone - a case report.
Plasma cell leukemia (PCL) is an aggressive disease with poor prognosis and a median survival of only 2-6 months. Currently, no standard therapy is available, but intensive polychemotherapy appears to be more effective than the conventional melphalan plus prednisone. However, the efficacy of thalidomide in PCL has not yet been widely evaluated. Recently, treatment with thalidomide has been repo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Indian Journal of Hematology and Blood Transfusion
سال: 2009
ISSN: 0971-4502,0974-0449
DOI: 10.1007/s12288-009-0019-1